Publications by authors named "Rachel Halford"

Claim this Profile
P
Peer-Delivered Hepatitis C Testing and Health Screening Provided in a Community Pharmacy Setting: Proof of Concept.
Neha Sankla, Ray Cottington, Chris Cowie, Paul Huggett, Leila Reid, Rachel Halford

Pharmacy (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Let's break it down: combating hepatitis stigma and discrimination.
Rachel Halford, Jessica Hicks, Md Reazul Islam, Cary James, Gamal Shiha

Lancet Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field.
Sheila F Lumley, Jolynne Mokaya, Tongai G Maponga, Anna Kramvis, Geoffrey Dusheiko, Rachel Halford

Lancet Microbe· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families.
Julie Jemutai, Louise Downs, Motswedi Anderson, Chari Cohen, Janet Seeley, Rachel Halford

Lancet Gastroenterol Hepatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-creating and implementing a novel pre-conference event to promote equity and inclusivity among academic researchers and people who use drugs.
M J Stowe, Louise Hansford, Rachel Halford, Jason Wallace, Lise Lafferty

Drug Alcohol Rev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
It is time for World Hepatitis Testing Week.
Rachel Halford, Jessica Hicks, Reazul Islam, Cary James, Luís Mendão

Lancet Gastroenterol Hepatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis.
Seth Inzaule, Philippa Easterbrook, Ashley Latona, Nathan P Ford, William Irving, Rachel Halford

Clin Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peer support for people living with hepatitis B virus-A foundation for treatment expansion.
Louise O Downs, Kenneth Kabagambe, Sarah Williams, Elizabeth Waddilove, Marion Delphin, Rachel Halford

J Viral Hepat· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time for a treat all approach for hepatitis B.
Rachel Halford, Danjuma Adda, Jessica Hicks, Cary James, Alexandra Smith

Lancet Gastroenterol Hepatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic hepatitis C elimination prison initiative: HCV-intensive test and treat, a whole prisoner population HCV test-and-treat program in England.
Rachel Halford, Lee Christensen, Sean Cox, Julia Sheehan, Iain Brew

Health Sci Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a Model of Delivering Hepatitis C Care in a Homeless Metropolitan Population in England.
María Fernanda Guerra-Veloz, Khin Han, Kathryn Oakes, David Robertson, Almuthana Mohamed, Rachel Halford

Am J Gastroenterol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of peer support in a hepatitis C elimination programme.
Davina Varsha Jugnarain, Rachel Halford, Stuart Smith, Matthew Hickman, Pantelis Samartsidis

J Viral Hepat· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C.
Graham S Cooke, Sarah Pett, Leanne McCabe, Chris Jones, Richard Gilson, Rachel Halford

Wellcome Open Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
Rob Bielen, Samya R Stumo, Rachel Halford, Klára Werling, Tatjana Reic

Harm Reduct J· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis